Delirium Clinical Trial
Official title:
Safety and Efficacy of Combined Sedation With Midazolam and Dexmedetomidine in ICU Patients
It is well known that ICU patients need sedation. Now no ideal sedation drug existed and every sedation drug has its advantage and disadvantage,so combined sedation may use the advantage and avoid the disadvantage of the sedation drug according to the patients'condition. Until now, there is rare study about the combined sedation or sequenced sedation of different sedation drug.The purpose of the study is to explore the value of combined sedation with midazolam and dexmedetomidine compared to single drug sedation in ICU, so as to seek an ideal sedation protocol that could reduce the cost of treatment,obtain the appropriate sedation not under sedation or over sedation,reduce the incidence of delirium, reduce the adverse event of sedation.
Status | Recruiting |
Enrollment | 600 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. ICU patients needing sedation 2. 18 years or older 3. mechanically ventilated for less than 96 hours prior to start of study drug. Exclusion Criteria: 1. Trauma and burn patients as admitting diagnosis. 2. Dialysis of all types. 3. Pregnant or lactation. 4. Neuromuscular blockade other than for intubation. 5. Epidural or spinal analgesia. 6. General anesthesia prior to or planned after the start of study drug infusion 7. Serious central nervous system pathology(acute stroke, uncontrolled seizures,severe dementia). 8. Acute hepatitis or severe liver disease (Child-Pugh class C). 9. Unstable angina or acute myocardial infarction. 10. Left ventricular ejection fraction less than 30%,heart rate less than 50/min. 11.Second or third degree heart block. 12.Allergy to the study drug. 13.Systolic blood pressure less than 90 mm Hg despite continuous infusions of 2 vasopressors before the start of study drug infusion. 14. Patients with renal insufficiency were randomized and treated; however, patients were discontinued if they required dialysis. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | Department ICU, Shandong university affiliated Qilu Hospital. | Jinan | Shandong |
Lead Sponsor | Collaborator |
---|---|
Qilu Hospital | Chinese Medical Association |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The total time within target sedation level | Sedation level with RASS score is recorded every 4 hours during sedation. When target sedation was not obtained, sedation drug dosage changed and when adverse event needed to be treated, the sedation level is also recorded. The adjustment of sedation drug is recorded. |
From sedation drug is used to weaning from sedation up to 28 days. | No |
Secondary | The dosage of sedation/analgesic drug | Record the induced and maintained dosage of sedation/opioid analgesic drug. The total dosage of sedation/opioid analgesic drug. The added dosage of midazolam. | From sedation/analgesic drug is used to weaning from sedation/analgesic up to 28 days. | No |
Secondary | Duration of mechanical ventilation | The duration of mechanical ventilation is recorded. | From beginning to weaning from ventilation up to 28 days.. | No |
Secondary | Economic outcome | The cost of sedation drug used is recorded. The cost of mechanical ventilation is recorded. The cost of ICU residency is recorded. | From admitted to ICU until ventilation and sedation stopped and participants discharged from ICU up to 28 days. | No |
Secondary | Satisfactory of patients to ICU stay from admitted until discharged from ICU | Evaluated the satisfactory of patients to ICU. Using scores including 0 to 10. 0 presents extremely dissatisfied and 10 presents extremely satisfied. | Assessed at time of 1 week participants discharged from ICU. | No |
Secondary | Delirium | Delirium is evaluated when daily sedation interruption is done during sedation. Delirium incidence is recorded using CAM-ICU. Treatment of delirium is recorded including drug,dosage and method of administration. | From sedation drug is used to weaning from sedation, up to 28 days. | Yes |
Secondary | Vital signs | Heart rate(HR),main arterial pressure(MAP),respiratory rate(RR),pulse saturate of oxygen(SPO2) are recorded every 4 hours. When sedation drug dosage changed and adverse events treated,the vital signs is also recorded. Gas blood analysis index is recorded when the daily interruption is done and when the SPO2 is less 90% or 10% decrease than normal. |
From sedation drug is used to weaning from sedation, up to 28 days. | Yes |
Secondary | Duration of ICU stay | Record when participants discharged form ICU. | From date of admission until participants discharged from ICU up to 28 days. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT05891873 -
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Recruiting |
NCT06194474 -
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
|
||
Completed |
NCT03095417 -
Improving the Recovery and Outcome Every Day After the ICU
|
N/A | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Not yet recruiting |
NCT04846023 -
Pediatric Delirium Screening in the PICU Via EEG
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Withdrawn |
NCT02673450 -
PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
|
||
Recruiting |
NCT03256500 -
Transcranial Direct Current Stimulation for the Treatment of Delirium
|
N/A | |
Completed |
NCT02890927 -
Geriatric-CO-mAnagement for Cardiology Patients in the Hospital
|
N/A | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Recruiting |
NCT03165539 -
Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
|
||
Completed |
NCT02518646 -
DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models
|
N/A | |
Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
Recruiting |
NCT02305589 -
The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium
|
N/A | |
Completed |
NCT02628925 -
Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale
|
N/A |